Daniel G. Baker Receives Stock Award at Artiva Biotherapeutics Inc (ARTV) — SEC Form 4, Sep 08, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Daniel G. Baker CIK 0002046802 |
Director
|
Daniel G. Baker at Artiva Biotherapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Artiva Biotherapeutics Inc
| 2026-09-14 | Award | — | View |
| 2025-06-26 | Award | — | View |
| 2025-01-29 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $10.88 | 2026-09-08 | A - Award/Grant | 13,750 A | $0.00 | 2036-09-07 | 13,750 Common Stock | Direct |
Footnotes (1)
- F1
- The shares subject to the option will vest in full on the earlier of September 8, 2027, or the date of the Issuer's 2027 annual stockholder meeting. Show more
Related filings at Artiva Biotherapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
72
institutional managers reporting a position
Largest by reported value
- Ra Capital Management, L.P. $174M
- Viking Global Investors Lp $25.3M
- Blackstone Inc $23.3M
5%+ Holders · 13D/G
3 filers
-
GC Corp 12.3%
Other insiders at Artiva Biotherapeutics Inc
-
Christopher Horan -$43.6K
-
Jennifer Bush -$35.3K
-
Subhashis Banerjee -$4.64K
-
Fred Aslan -$260K
-
Fred Aslan -$169K
GET /v1/forms/4/0001193125-26-385412
API docs
View Original SEC Filing